After reading this thread, I contacted them to find out more about the purpose of this study.
Here is the message I sent:
Hello,
I have a fairly simple question regarding your study of the electronic cigarette. Hopefully you can shoot me a quick answer...
Is this study meant to measure smoking cessation, or nicotine cessation?
I have been using the device for a couple of weeks now, and haven't smoked a cigarette since I picked up the e-cig. So I have stopped inhaling the smoke, but I am still getting nicotine (24 mg strength, not 16). Personally it isn't about wanting to stop using nicotine for me, but rather smoking and the adverse effects it causes. I think that is an important distinction that you should be a bit more clear on in your study. Many e-cig users are watching for your results and while we are very happy to see a serious study, we are a bit concerned that rather than focusing on the actual act of inhaling "smoke" vs inhaling "vapor", this study might be focusing on the ability of e-cigs to stop nicotine addiction. Could you please let us all know which of these your study is focusing on?
Thank you,
Kenny (12 days smoke-free with no cravings)
This morning, I awoke to the following response:
Dear Kenny
Thanks for your enquiry.
I'm pleased to hear that you have found e-cigarettes helpful in weaning
off tobacco cigarettes.
This seems to be a very common experience, so for me that's a good enough
reason to apply a scientific approach to measure how effective
e-cigarettes are at helping smokers to quit tobacco cigarettes. That is
the primary aim of our trial.
We will also measure if changes in dependence on nicotine occur along with
many other things such as cravings and withdrawal symptoms, acceptability
and ease of use, and adverse effects. But these are of secondary interest.
the main thing we are interested in is quitting smoking. Tobacco smoke
is what kills people, not nicotine.
We will be following the participants for 6 months after the day they stop
smoking cigarettes and start their e-cigarettes.
The study will get underway in earnest in early 2011 and run over about 18
months.
I hope this answers your questions.
Best wishes for a smokefree future
Chris
Associate Professor Chris Bullen
Principal Investigator, ASCEND study
Director, Clinical Trials Research
National Institute of Health Innovation
The University of Auckland